Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status-Reference-Cited by-同舟云学术

Health-related quality of life in patients with metastatic colorectal cancer, association with systemic inflammatory response and RAS and BRAF mutation status

Published:2017-08 Issue: Volume:81 Page:26-35
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Thomsen Maria,Guren Marianne Grønlie,Skovlund Eva,Glimelius Bengt,Hjermstad Marianne Jensen,Johansen Julia S.,Kure Elin,Sorbye Halfdan,Pfeiffer Per,Christoffersen Thoralf,Guren Tormod Kyrre,Tveit Kjell Magne

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference40 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer;Van Cutsem;Ann Oncol,2016

4. Addition of cetuximab to oxaliplatin-based first-line combination chemotherapy for treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial;Maughan;Lancet,2011

5. FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study;Cremolini;Lancet Oncol,2015

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Do older patients with colorectal cancer experience more deterioration in health-related quality of life than younger patients during the first year of palliative chemotherapy? A prospective real-world observational study;Journal of Geriatric Oncology;2024-04

2. Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis;BMC Cancer;2024-02-09

3. Research Progress on the Relationship between IL-6 and the Treatment and Prognosis of Colorectal Cancer;Advances in Clinical Medicine;2023

4. Gemcitabine: An Alternative Treatment for Oxaliplatin-Resistant Colorectal Cancer;Cancers;2022-11-29